| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8877d26e7e712d48efb03a75bd073f3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 |
| filingDate |
2014-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fee6d336ef7fbd5cabd4aa6960280812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a4c8fb9004bc0bf3d0b44b0ab37ceb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c0cb7461fba4ba9a6841b2ab7cd1d41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0571e285fdc04c020c8687c166ebe111 |
| publicationDate |
2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2959907-A1 |
| titleOfInvention |
Orally administered adsorbent, therapeutic agent for renal disease, and therapeutic agent for liver disease |
| abstract |
An object of the present invention is to provide spherical activated carbon exhibiting excellent adsorption ability for uremic substances in the body, and particularly for β-aminoisobutyric acid. Accordingly, provided is an orally administered adsorbent comprising spherical activated carbon containing not less than 0.5 wt% of nitrogen atoms, having a specific surface area determined by the Brunauer-Emmett-Teller (BET) method of 700 m 2 /g to 3000 m 2 , and having an average particle size from 0.01 to 1 mm. |
| priorityDate |
2013-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |